Kazimierz Kuliczkowski is a scholar working on Hematology, Genetics and Molecular Biology.
According to data from OpenAlex, Kazimierz Kuliczkowski has authored 202 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hematology, 68 papers in Genetics and 59 papers in Molecular Biology. Recurrent topics in Kazimierz Kuliczkowski's work include Chronic Lymphocytic Leukemia Research (46 papers), Lymphoma Diagnosis and Treatment (40 papers) and Acute Myeloid Leukemia Research (35 papers). Kazimierz Kuliczkowski is often cited by papers focused on Chronic Lymphocytic Leukemia Research (46 papers), Lymphoma Diagnosis and Treatment (40 papers) and Acute Myeloid Leukemia Research (35 papers). Kazimierz Kuliczkowski collaborates with scholars based in Poland, United States and United Kingdom. Kazimierz Kuliczkowski's co-authors include Grzegorz Mazur, Dariusz Wołowiec, Tomasz Wróbel, Bruno Quesnel, Abdelbasset Hamrouni, Aurore Saudemont, Jizhong Liu, Valérie Coiteux, Dominique Hétuin and Justyna Rybka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Kazimierz Kuliczkowski
197 papers
receiving
3.5k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis
2015340 citationsKazimierz Kuliczkowski et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Kazimierz Kuliczkowski
Since
Specialization
Citations
This map shows the geographic impact of Kazimierz Kuliczkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazimierz Kuliczkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazimierz Kuliczkowski more than expected).
Fields of papers citing papers by Kazimierz Kuliczkowski
This network shows the impact of papers produced by Kazimierz Kuliczkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazimierz Kuliczkowski. The network helps show where Kazimierz Kuliczkowski may publish in the future.
Co-authorship network of co-authors of Kazimierz Kuliczkowski
This figure shows the co-authorship network connecting the top 25 collaborators of Kazimierz Kuliczkowski.
A scholar is included among the top collaborators of Kazimierz Kuliczkowski based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Kazimierz Kuliczkowski. Kazimierz Kuliczkowski is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Robak, Tadeusz, Sebastian Grosicki, Krzysztof Warzocha, et al.. (2015). Ofatumumab (O) in combination with fludarabine (F) and cyclophosphamide (C) (OFC) vs. FC in patients with relapsed chronic lymphocytic leukaemia (CLL): results of the phase III study complement 2. Haematologica. 100.3 indexed citations
Crump, M., Adriana Scheliga, Jiří Mayer, et al.. (2011). Efficacy and safety of bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed, R-naive/-sensitive follicular lymphoma (FL): outcome according to prior therapy. Annals of Oncology. 22. 186–186.1 indexed citations
Karabon, Lidia, Anna Tomkiewicz, Dariusz Wołowiec, et al.. (2011). ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population. SHILAP Revista de lepidopterología.1 indexed citations
9.
Usnarska‐Zubkiewicz, Lidia, et al.. (2011). AL Amyloidosis (Amyloidosis Antibody Light). Part 2 – Epidemiology, Clinical Symptoms, Diagnosis and Treatment of Amyloidosis AL. Advances in Clinical and Experimental Medicine. 20(6). 771–778.1 indexed citations
Mazur, Grzegorz, Emilia Jaskuła, Ilona Kryczek, et al.. (2011). Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin’s lymphoma. SHILAP Revista de lepidopterología.2 indexed citations
12.
Kimby, Eva, Adriana Scheliga, Jiří Mayer, et al.. (2011). FCGR3A polymorphism does not significantly affect response and outcome of follicular lymphoma patients treated in the PRIMA study with rituximab and chemotherapy followed by rituximab maintenance or observation. Annals of Oncology. 22. 187–187.1 indexed citations
13.
Steegmann, J. L., Mauricette Michallet, Enrica Morra, et al.. (2010). A european observational study of dasatinib in the management of imatinib-resistant and -intolerant patients with chronic myeloid leukemia: forte study (ca180-211). 95. 339–339.1 indexed citations
14.
Nawrot, Urszula, et al.. (2010). Fungal Contamination of Air in the Department of Haematology. Polish Journal of Environmental Studies. 19(5). 967–971.1 indexed citations
15.
Kapelko‐Słowik, Katarzyna, Donata Urbaniak‐Kujda, Dariusz Wołowiec, et al.. (2010). Human Pim-2 Gene Expression in Acute Myeloid and Acute Lymphoblastic Leukemia Patients and Complete Remission. Advances in Clinical and Experimental Medicine. 19(1). 99–104.1 indexed citations
Wróbel, Tomasz, et al.. (2006). Effect of Exogenous Melatonin on Rat Haematopoietic Cells Exposed to Cytosine Arabinoside and Etoposide. Advances in Clinical and Experimental Medicine. 15(6). 979–982.1 indexed citations
18.
Poręba, Małgorzata, Lidia Usnarska‐Zubkiewicz, Bożena Jaźwiec, Rafał Poręba, & Kazimierz Kuliczkowski. (2006). Expression of CD105 Antigen in Patients with Acute Leukemia, Malignant Lymphoma, and Multiple Myeloma in Active Phase of the Disease. Advances in Clinical and Experimental Medicine. 15(6). 1023–1028.1 indexed citations
19.
Mazur, Grzegorz, Agnieszka Hałoń, Tomasz Wróbel, & Kazimierz Kuliczkowski. (2004). Macrophage/histiocytic antigen CD68 expression in neoplastic and reactive lymph nodes.. PubMed. 49 Suppl 1. 73–5.5 indexed citations
20.
Mazur, Grzegorz, Tomasz Wróbel, Maria Podolak‐Dawidziak, et al.. (2004). [Anagrelide in the treatment of thrombocythemia essential (ET)].. PubMed. 112(6). 1445–50.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.